Reciprocal expression of trefoil factor‐1 and thyroid transcription factor‐1 in lung adenocarcinomas

Molecular targeted therapies against EGFR and ALK have improved the quality of life of lung adenocarcinoma patients. However, targetable driver mutations are mainly found in thyroid transcription factor‐1 (TTF‐1)/NK2 homeobox 1 (NKX2‐1)‐positive terminal respiratory unit (TRU) types and rarely in no...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubara, Daisuke, Yoshimoto, Taichiro, Soda, Manabu, Amano, Yusuke, Kihara, Atsushi, Funaki, Toko, Ito, Takeshi, Sakuma, Yuji, Shibano, Tomoki, Endo, Shunsuke, Hagiwara, Koichi, Ishikawa, Shumpei, Fukayama, Masashi, Murakami, Yoshinori, Mano, Hiroyuki, Niki, Toshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293082/
https://www.ncbi.nlm.nih.gov/pubmed/32237253
http://dx.doi.org/10.1111/cas.14403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293082/
https://www.ncbi.nlm.nih.gov/pubmed/32237253
http://dx.doi.org/10.1111/cas.14403

Ejemplares similares